During the past decade, Department of Neurology, CHU Mont-Godinne conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Neurology, CHU Mont-Godinne" #1 collaborator was "Université Catholique de Louvain" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Department of Neurology, CHU Mont-Godinne" are "Stroke" (3 trials) and "Hemiparesis" (1 trials). Many other conditions were trialed in "Department of Neurology, CHU Mont-Godinne" in a lesser frequency.

Most popular intervention types in "Department of Neurology, CHU Mont-Godinne" are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Bimanual motor skill learning with the REAplan(R) rehabilitation robot" (1 trials), "tdcs (ELDITH, Neuroconn, Ilmenau, Germany)" (1 trials), "transcranial direct current stimulation tDCS" (1 trials) and "transcranial magnetic stimulation TMS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Neurology, CHU Mont-Godinne" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Department of Neurology, CHU Mont-Godinne". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Department of Neurology, CHU Mont-Godinne, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Neurology, CHU Mont-Godinne, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".